Molecular Diagnostics


Important breakthroughs in high throughput sample preparation, next generation sequencing technology, data management and detection technology has provided a strong impetus to the development of new molecular diagnostic techniques. In the USA, a focus on the early detection of bio-terrorism threats and potential pandemics such as avian influenza has spawned a considerable number of companies and significant early stage funding.

BioFuture is focused on supporting companies in:

  • formulating go-to-market strategies, with special emphasis on international markets.
  • prospecting for potential partners to fill gaps in workflow and assay kit development.
  • negotiating favorable terms for drop in kit reagents, including licensing strategies.
  • establishing distributor networks in developing countries.
  • onboarding logistics and SOP formulation for new partners.
200 OK


The server encountered an internal error or misconfiguration and was unable to complete your request.

Please contact the server administrator, [no address given] and inform them of the time the error occurred, and anything you might have done that may have caused the error.

More information about this error may be available in the server error log.